Report EU - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Feb 1, 2025

EU - Other Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

EU: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in the EU

The EU market for other medicaments for therapeutic or prophylactic uses skyrocketed to $X in 2022, with an increase of X% against the previous year. The total consumption indicated strong growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by X% against 2020 indices. Over the period under review, the market reached the maximum level in 2022 and is expected to retain growth in years to come.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in the EU

In value terms, production of other medicaments for therapeutic or prophylactic uses surged to $X in 2022 estimated in export price. The total output value increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. As a result, production reached the peak level and is likely to continue growth in the immediate term.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports in the EU

In 2022, exports of other medicaments for therapeutic or prophylactic uses in the European Union expanded remarkably to X tons, picking up by X% compared with the previous year's figure. Overall, exports, however, continue to indicate a perceptible decline. The growth pace was the most rapid in 2020 when exports increased by X%. Over the period under review, the exports of reached the maximum at X tons in 2013; however, from 2014 to 2022, the exports failed to regain momentum.

In value terms, exports of other medicaments for therapeutic or prophylactic uses rose notably to $X in 2022. In general, exports continue to indicate a mild expansion. The pace of growth appeared the most rapid in 2018 when exports increased by X%. As a result, the exports attained the peak of $X. From 2019 to 2022, the growth of the exports of remained at a somewhat lower figure.

Exports by Country

Spain (X tons), France (X tons), Belgium (X tons), Italy (X tons), the Netherlands (X tons), Germany (X tons), Ireland (X tons), Sweden (X tons) and Portugal (X tons) represented roughly X% of total exports in 2022.

From 2012 to 2022, the biggest increases were recorded for Belgium (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest other medicaments for therapeutic or prophylactic uses supplying countries in the European Union were Portugal ($X), Spain ($X) and Germany ($X), together accounting for X% of total exports.

In terms of the main exporting countries, Portugal, with a CAGR of X%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in the European Union stood at $X per ton in 2022, rising by X% against the previous year. Over the period under review, the export price saw a strong expansion. The pace of growth was the most pronounced in 2018 when the export price increased by X% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2019 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Portugal ($X per ton), while Belgium ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Portugal (X%), while the other leaders experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports in the EU

In 2022, imports of other medicaments for therapeutic or prophylactic uses in the European Union skyrocketed to X tons, rising by X% on 2021 figures. Total imports indicated resilient growth from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, imports reached the peak and are likely to continue growth in the immediate term.

In value terms, imports of other medicaments for therapeutic or prophylactic uses rose rapidly to $X in 2022. In general, imports recorded a strong expansion. The pace of growth appeared the most rapid in 2018 when imports increased by X%. As a result, imports reached the peak of $X. From 2019 to 2022, the growth of imports of remained at a somewhat lower figure.

Imports by Country

Germany was the major importing country with an import of around X tons, which amounted to X% of total imports. France (X tons) held the second position in the ranking, followed by Spain (X tons), the Netherlands (X tons), Italy (X tons) and Belgium (X tons). All these countries together held approx. X% share of total imports. Poland (X tons) followed a long way behind the leaders.

Germany was also the fastest-growing in terms of the other medicaments for therapeutic or prophylactic uses imports, with a CAGR of X% from 2012 to 2022. At the same time, Belgium (X%), France (X%) and Italy (X%) displayed positive paces of growth. Spain experienced a relatively flat trend pattern. By contrast, the Netherlands (X%) and Poland (X%) illustrated a downward trend over the same period. From 2012 to 2022, the share of Germany, France and Belgium increased by X, X and X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest other medicaments for therapeutic or prophylactic uses importing markets in the European Union were Spain ($X), Germany ($X) and Italy ($X), together comprising X% of total imports.

Germany, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in the European Union amounted to $X per ton, with a decrease of X% against the previous year. Over the period under review, the import price recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2018 an increase of X% against the previous year. As a result, import price reached the peak level of $X per ton. From 2019 to 2022, the import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Spain ($X per ton), while France ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Spain (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The countries with the highest volumes of consumption of other medicaments for therapeutic or prophylactic uses in 2020 were Italy, the Netherlands and France, with a combined 55% share of total consumption. Germany, Belgium, Poland, Ireland, the Czech Republic, Austria, Portugal, Sweden, Bulgaria and Denmark lagged somewhat behind, together accounting for a further 37%.
Italy remains the largest other medicaments for therapeutic or prophylactic uses producing country in the European Union, comprising approx. 37% of total volume. Moreover, production of other medicaments for therapeutic or prophylactic uses in Italy exceeded the figures recorded by the second-largest producer, France, threefold. Belgium ranked third in terms of total production with an 11% share.
In value terms, the Netherlands remains the largest other medicaments for therapeutic or prophylactic uses supplier in the European Union, comprising 50% of total exports. The second position in the ranking was occupied by Germany, with an 11% share of total exports. It was followed by Spain, with a 10% share.
In value terms, the Netherlands constitutes the largest market for imported other medicaments for therapeutic or prophylactic uses in the European Union, comprising 52% of total imports. The second position in the ranking was occupied by Ireland, with a 17% share of total imports. It was followed by Spain, with an 8.6% share.
In 2020, the export price for other medicaments for therapeutic or prophylactic uses in the European Union amounted to $87,106 per ton, declining by -9.1% against the previous year.
The import price for other medicaments for therapeutic or prophylactic uses in the European Union stood at $58,126 per ton in 2020, picking up by 29% against the previous year.

This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in the EU. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in the EU, split by region and country
  • Trade (exports and imports) in the EU
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY
  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2024
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2024
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Austria
    • Belgium
    • Bulgaria
    • Croatia
    • Cyprus
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Greece
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg
    • Malta
    • Netherlands
    • Poland
    • Portugal
    • Romania
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
  12. LIST OF TABLES

    1. Key Findings In 2024
    2. Market Volume, In Physical Terms, 2012–2024
    3. Market Value, 2012–2024
    4. Per Capita Consumption, By Country, 2018–2024
    5. Production, In Physical Terms, By Country, 2012–2024
    6. Imports, In Physical Terms, By Country, 2012–2024
    7. Imports, In Value Terms, By Country, 2012–2024
    8. Import Prices, By Country Of Destination, 2012–2024
    9. Exports, In Physical Terms, By Country, 2012–2024
    10. Exports, In Value Terms, By Country, 2012–2024
    11. Export Prices, By Country Of Origin, 2012–2024
  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2024
    2. Market Value, 2012–2024
    3. Consumption, By Country, 2024
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2024
    18. Production, In Value Terms, 2012–2024
    19. Production, By Country, 2024
    20. Production, In Physical Terms, By Country, 2012–2024
    21. Imports, In Physical Terms, 2012–2024
    22. Imports, In Value Terms, 2012–2024
    23. Imports, In Physical Terms, By Country, 2024
    24. Imports, In Physical Terms, By Country, 2012–2024
    25. Imports, In Value Terms, By Country, 2012–2024
    26. Import Prices, By Country, 2012–2024
    27. Exports, In Physical Terms, 2012–2024
    28. Exports, In Value Terms, 2012–2024
    29. Exports, In Physical Terms, By Country, 2024
    30. Exports, In Physical Terms, By Country, 2012–2024
    31. Exports, In Value Terms, By Country, 2012–2024
    32. Export Prices, 2012–2024

Recommended reports

Free Data: Medicaments; (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) - European Union